Commutability of external quality assessment materials for point‐of‐care glucose testing using the Clinical and Laboratory Standards Institute and International Federation of Clinical Chemistry approaches
Open Access
- 27 April 2020
- journal article
- research article
- Published by Wiley in Journal of Clinical Laboratory Analysis
- Vol. 34 (8) , e23327
Abstract
Objectives: The aim of this study was to assess the commutability of three external quality assessment (EQA) materials for point‐of‐care (POC) glucose testing using two approaches, to identify suitable EQA materials to evaluate and monitor the quality of POC testing. Methods: Commercial control materials (CCMs), pooled human serum samples (PHSs), and homemade human whole‐blood samples (HWBs) were measured along with 33 individual clinical samples using five POC instruments and a Hitachi 7600 analyzer. Data were analyzed by Deming regression analysis with a 95% prediction interval as described in Clinical and Laboratory Standards Institute (CLSI) EP30‐A, and by difference in bias analysis as described by the International Federation of Clinical Chemistry (IFCC) Working Group on Commutability. Results: Using the CLSI approach, HWBs, CCMs, and PHSs were commutable with five, one, and two instruments, respectively. With the IFCC approach, HWBs were commutable with two instruments, while CCMs and PHSs were largely inconclusive or non‐commutable on five instruments. Conclusions: HWBs were commutable on all instruments by the CLSI approach and may be a suitable EQA material for POC testing. Although some results differed between the IFCC and CLSI approaches, both indicated that HWBs were far superior to CCMs and PHSs in commutability.Keywords
Funding Information
- National Clinical Key Specialty Construction Projects
- Beijing Capital Development Special Project for Health Research (2016-1-2031)
This publication has 29 references indexed in Scilit:
- Application of the Reference Method Isotope Dilution Gas Chromatography Mass Spectrometry (ID/GC/MS) to Establish Metrological Traceability for Calibration and Control of Blood Glucose Test SystemsJournal of Diabetes Science and Technology, 2014
- Point-of-care testing: where is the evidence? A systematic surveyClinical Chemistry and Laboratory Medicine (CCLM), 2013
- Analytical Characteristics of High-Sensitivity Cardiac Troponin AssaysClinical Chemistry, 2012
- Proficiency Testing/External Quality Assessment: Current Challenges and Future DirectionsClinical Chemistry, 2011
- Assuring Quality in Point-of-Care Testing: Evolution of Technologies, Informatics, and Program ManagementArchives of Pathology & Laboratory Medicine, 2011
- Guidelines and Recommendations for Laboratory Analysis in the Diagnosis and Management of Diabetes MellitusClinical Chemistry, 2011
- Point of care testing in a large urban academic medical center: Evolving test menu and clinical applicationsClinica Chimica Acta, 2010
- Self-monitoring of blood glucose with a focus on analytical quality: an overviewClinical Chemistry and Laboratory Medicine (CCLM), 2010
- Interference of Maltose, Icodextrin, Galactose, or Xylose with Some Blood Glucose Monitoring SystemsPharmacotherapy: The Journal of Human Pharmacology and Drug Therapy, 2007
- Performance Evaluation of Blood Glucose Monitoring DevicesDiabetes Technology & Therapeutics, 2003